torsemide has been researched along with Absence Seizure in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lambert, D; Masereel, B; Pochet, L; Wouters, J | 1 |
| Gramer, M; Hampel, P; Löscher, W; Römermann, K | 1 |
| Gailus, B; Gericke, B; Hampel, P; Johne, M; Kaczmarek, E; Löscher, W; Römermann, K | 1 |
| Delarge, J; Dogné, JM; Lambert, DM; Masereel, B; Poupaert, JH | 1 |
4 other study(ies) available for torsemide and Absence Seizure
| Article | Year |
|---|---|
Design, synthesis, and anticonvulsant activity of 1-(pyrid-3-ylsulfonamido)-2-nitroethylenes.
Topics: Animals; Anticonvulsants; Convulsants; Crystallography, X-Ray; Drug Design; Electroshock; Male; Mice; Mice, Inbred Strains; Models, Molecular; Molecular Conformation; Molecular Structure; Neurotoxins; Phenytoin; Seizures; Stereoisomerism; Structure-Activity Relationship; Thiourea | 1998 |
The search for brain-permeant NKCC1 inhibitors for the treatment of seizures: Pharmacokinetic-pharmacodynamic modelling of NKCC1 inhibition by azosemide, torasemide, and bumetanide in mouse brain.
Topics: Animals; Brain; Bumetanide; Endothelial Cells; Humans; Mice; Seizures; Sodium Potassium Chloride Symporter Inhibitors; Solute Carrier Family 12, Member 2; Sulfanilamides; Torsemide | 2021 |
Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice.
Topics: Animals; Anticonvulsants; Bumetanide; Drug Therapy, Combination; Epilepsy; Female; Mice; Phenobarbital; Pilocarpine; Seizures; Sodium Potassium Chloride Symporter Inhibitors; Solute Carrier Family 12, Member 2; Sulfanilamides; Torsemide; Treatment Outcome | 2021 |
Anticonvulsant activity of pyrid-3-yl-sulfonyl ureas and thioureas.
Topics: Animals; Anticonvulsants; Diuretics; Epilepsy; Male; Mice; Neuroprotective Agents; Seizures; Sulfonamides; Sulfonylurea Compounds; Thiourea; Torsemide | 1997 |